Suven Life Sciences Ltd.
SUVEN Share PricePharmaceuticals & Drugs
₹233.36
11.1 (5%)
As on September 8, 2025
Exchange Scrips: BSE530239NSESUVENISININE495B01038
Market Cap ₹ 5,307 Cr
P/E Ratio -31.66
Dividend Yield N/A
Performance
Market performance
Open222.25
High233.36
Volumes57,449
Prev233.36
Low222
As on2025-09-08
Historical performance
1 Year High299.99
3 Year High299.99
5 Year High299.99
1 Year Low102.5
3 Year Low45
5 Year Low40.49
Fundamentals
Company Valuation
Market Cap (₹Cr)
5,307
Face Value (₹)
1
P/E Ratio
-31.66
Dividend Yield
N/A
Investment Returns
1 Year
55%
3 Years
222.3%
5 Years
438.9%
10 Years
25.4%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 220.18 | Bullish |
| 10-DMA | 218.35 | Bullish |
| 20-DMA | 227.05 | Bullish |
| 50-DMA | 253.86 | Bearish |
| 100-DMA | 223.67 | Bullish |
| 200-DMA | 175.04 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 66153 | 64597 | 63531 | 63969 | 66110 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -31.66.
- 3Y Stock Price CAGR of the stock is 48.9.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹-1548 Million.
- The company generated revenue of ₹67 Million in the previous financial year.
Suven Life Sciences Ltd.
233.3611.1 (5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1513163
No. of Shares: 6484 (Approx)
Performance:51.3%
P/L: ₹513163
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent